December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

3.870 -0.220 (-5.38%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
News headline image
Psychedelic Stock Gainers And Losers From March 27, 2023 ↗
 
Via Benzinga
News headline image
Expert Ratings for ATAI Life Sciences ↗
 
Via Benzinga
News headline image
ATAI Life Sciences Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026 ↗
Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show: 
Via Benzinga
News headline image
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
From atai Life Sciences
Via GlobeNewswire
News headline image
The Latest Analyst Ratings for ATAI Life Sciences ↗
 
Via Benzinga
News headline image
Atai Layoffs 2023: What to Know About the Latest ATAI Job Cuts ↗
Atai Life Sciences has just announced 30% job cuts. Here's how investors should be interpreting the Atai layoffs as ATAI stock rises. 
Via InvestorPlace
News headline image
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 22, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 21, 2023 ↗
 
Via Benzinga
News headline image
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion ↗
This is the third article of a three-part series, you can find the first and 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 20, 2023 ↗
 
Via Benzinga
News headline image
An Update On The Performance Of The 7 Largest Psychedelic Stocks ↗
The 7 largest psychedelic drug stocks are ranked as to their stock performances since the beginning of March and year-to-date, their likelihood of financial distress, analyst price forecasts and the... 
Via Talk Markets
News headline image
The "Rags-To-Riches" Portfolio: An Update ↗
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 17, 2023 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga
News headline image
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More ↗
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial 
Via Benzinga
News headline image
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event ↗
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll... 
Via Benzinga
News headline image
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 9, 2023 ↗
 
Via Benzinga
News headline image
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 6, 2023 ↗
 
Via Benzinga
News headline image
Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce ↗
The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant... 
Via Benzinga
News headline image
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.